Woman and Man
- | Country :
- United States
- | organs : -
- | Specialty : -
Extract
The objective of this study is to provide access to cabozantinib for eligible subjects with medullary thyroid cancer (MTC) pending approval of Exelixis' New Drug Application (NDA) by the FDA and commercial availability of cabozantinib.
Inclusion criteria
- Medullary Thyroid Cancer